Cefaclor
It is a semi-synthetic cephalo-sporin, having a broad spectrum anti bacterial activityOtitis media. Upper respiratory infections including pharyngitis and tonsillitis. Other ENT infections like acute rhinosinusitis, acute laryngitis, epiglottitis and external otitis. Lower respiratory infections including pneumonia and bronchitis (acute bronchitis or exacerbation of chronic bronchitis). Skin and skin-structure infections including impetigo, pyoderma, cellulitis subcutaneous abscess and post-traumatic or post-operative wound infections. Urinary tract infections including cystiti
Adults: 250 mg 8 hrly Max 500 mg 8 hrly. Children: 20 mg/kg/day in divided doses 8 hrly. In serious infections 40 mg/kg/day with Max 1 gm/day
Patients with known allergy to cephalosporins.
In penicillin sensitive patients, chronic renal failure, Pseudomembranous colitis, Infants less than 1 month. Paediatrics: Reduced dose necessary because of increased risk of skin reaction. Pregnancy: No evidence of risk. Lactation: The drug passes into breast milk and may affect the infant.
Hypersensitivity reactions, diarrhoea, nausea, vomiting, transient hepatitis, eosinophilia, genital pruritus or vaginitis, reversible interstitial nephritis.
Enhance nephrotoxicity of gentamycin and tobramycin. Probenecid slows tubular excretion.
Brand Name | Manufactured by |
---|---|
Corticlob | FINECURE PHARMA |